CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $52.04 | $520K | 15,480 |
| 2024-06-28 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 5,000 | ||
| 2024-06-27 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $22.50 | $225K | 25,480 |
| 2024-06-27 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $51.93 | $519K | 15,480 |
| 2024-06-27 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 15,000 | ||
| 2024-06-26 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $22.50 | $225K | 25,480 |
| 2024-06-26 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $51.82 | $518K | 15,480 |
| 2024-06-26 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 25,000 | ||
| 2024-06-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $8.11 | $81K | 178,176 |
| 2024-06-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $49.43 | $494K | 168,176 |
| 2024-06-18 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 11,715 | ||
| 2024-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Restricted Stock Units | +20,137 | 20,137 | ||
| 2024-06-12 | Posard Matthew L. Director | Sale | −10,000 | $50.62 | $506K | 99,755 |
| 2024-06-11 | Posard Matthew L. Director | Sale | −10,000 | $50.01 | $500K | 109,755 |
| 2024-05-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $8.11 | $81K | 178,176 |
| 2024-05-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $45.38 | $454K | 168,176 |
| 2024-05-22 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 21,715 | ||
| 2024-05-21 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion 10b5-1 | +10,000 | $8.11 | $81K | 178,176 |
| 2024-05-21 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −10,000 | $45.16 | $452K | 168,176 |
| 2024-05-21 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −10,000 | 31,715 |
Page 29 of 48 · 944 trades